companydata.dkcompanydata.dk

Idun Biologics ApS: Financial statements 2024

CVR: 43750380

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Idun Biologics ApS (CVR 43750380) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 516,626 and a net result of DKK -192,043 compared with DKK -2,287 the year before. That is a decrease of 22% compared with the year before. Equity in the 2024 report amounted to DKK -154,330. The company had 2 employees in the financial year.

Gross Profit
DKK 516,626
Profit/Loss
DKK -192,043
Equity
DKK -154,330
Total Assets
DKK 833,559
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-517K-192K-154K2
2023-662K-2K38K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Idun Biologics ApS: The 2023 annual report is outApr 23, 2024

Idun Biologics ApS has published its annual report for 2023. Gross profit came to DKK 662,220, and the net result was DKK -2,287.

About Idun Biologics ApS

Idun Biologics ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Clarisse Eve Chiche-Lapierre and Jens Frederik Teilfeldt Hansen. The company is owned by Ymir Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 475,329 and a net result of DKK -85,011 compared with DKK -192,043 the year before. Equity in the 2025 report amounted to DKK -239,341.

Source: annual report 2025, Danish Business Authority

Other financial years